Top of this page
Skip navigation, go straight to the content

Our Company Funding Other countries

Other countries

Donations

For the benefit of a cause and/or of the patients, UCB provides financial or other support in the form of Donations to organisations/institutions that raise awareness of the needs of those with severe diseases, that further medical and scientific knowledge, and that build strong communities in areas where UCB operates.

How to Apply

If your request is directed to UCB Corporate Headquarters, or a UCB affiliate for one of the following countries, follow this link to submit a Donation request: https://erequest.ucb.com/

  • Africa and Middle-East: all countries;
  • Europe and EFPIA* representation: all countries;
  • Asia: all countries except China;
  • Americas: all countries (for the USA, please consult the dedicated US page).

For Australia & China, or for further guidance, kindly contact the UCB Medical Affairs department in your country for assistance.

Grants

UCB is committed to improving patient care and will consider providing financial support to institutions (e.g., academic), associations (e.g., of medical professionals or patients) or recognised third party medical education providers for independent medical educational programmes and resources that address healthcare knowledge gaps and provide non-promotional information to patients and/or healthcare providers.

We support high quality, independent education through unrestricted educational grants focused on enhancing medical professional and patient awareness, knowledge, and education. Supported programmes must be objective, balanced and scientifically rigorous. In addition, all programmes must be in full compliance with applicable laws, regulations, and guidelines, including those established by relevant regulatory agencies and industry associations.

Examples of programmes that may be considered for funding:

  • Medical meetings and congress symposia for healthcare providers;
  • Training workshops for healthcare providers and patients;
  • Educational tools or resources to enhance physician-patient dialogue about treatment of disease;
  • Innovative technology platforms that enhance management of disease and aim to improve patient lives and their care.

Areas of Interest

Axial Spondyloarthritis / Ankylosing SpondylitisParkinson's Disease
Bone (Low Bone Mass Disorder)Psoriatic Arthritis
Crohn's DiseaseRestless Legs Syndrome
EpilepsyRheumatoid Arthritis
Family Planning and PregnancySystemic Lupus Erythematosus

How to Apply

Requests must be received at least 60 days prior to the date of the programme or event in order to be considered for funding.

All requests are reviewed on the basis of merit, unmet needs, company areas of interest, compliance with legal, ethical and professional obligations and fiscal responsibility.

Discretionary funding decisions are made by UCB and communicated to the party submitting the request.

If your request is directed to UCB Corporate Headquarters, or a UCB affiliate for one of the following countries, follow this link to submit a Grant request: https://erequest.ucb.com/

  • Africa and Middle-East: all countries;
  • Europe and EFPIA* representation: all countries;
  • Asia: all countries except China;
  • Americas: all countries (for the USA, please consult the dedicated US page).

For Australia & China, or for further guidance, kindly contact the UCB Medical Affairs department in your country for assistance.

Investigator-Initiated Studies

The aim of the UCB Investigator-Initiated Studies (IIS) programme is to support unsolicited, and independently initiated and conducted, studies that have the potential to enhance medical and scientific knowledge.

Therapeutic Areas of Interest

UCB is primarily focused on the following areas of therapeutic expertise (alphabetically listed):

Ankylosing SpondylitisParkinson's Disease
Axial SpondyloarthritisPsoriatic Arthritis
Crohn's DiseaseRestless Legs Syndrome
EpilepsyRheumatoid Arthritis
Low Bone Mass DisorderSystemic Lupus Erythematosus

UCB will also consider innovative ideas that enhance patient care and advance scientific knowledge.

UCB support may be provided in the form of funding and/or investigational drugs (product or compound manufactured/owned by UCB).

Timelines

Month in Review Review Type Submission Due Date
JanuaryConcept26 December 2017
FebruaryConcept15 January 2018
MarchConcept12 February 2018 (Immunology only)
AprilConcept14 March 2018
MayConcept17 April 2018
JuneConcept14 May 2018
JulyConcept11 June 2018 (Immunology only)
AugustConcept16 July 2018
SeptemberConcept13 August 2018
OctoberConcept17 September 2018
NovemberConcept22 October 2018
DecemberConcept12 November 2018

Submitting a Concept

UCB is using the eRequest on-line submission portal to manage all Investigator-Initiated Study requests worldwide. To submit a concept, please click here: https://erequest.ucb.com/

If a concept is recommended for a full proposal submission, an IIS Team member will contact the applicant with instructions.

eRequest is available for IIS submissions worldwide.

Contact

You can contact your local UCB Medical Science Liaison or UCB Medical Affairs office in your country.

All IIS process queries should be sent to IISmailbox@ucb.com.

Sponsorships

UCB accepts requests for Sponsorships to support activities which further medical and scientific knowledge. In return, UCB receives benefits such as opportunities to promote our products, our company, and/or specific disease awareness activities (e.g., booth, exhibit or other associated activities).

Areas of Interest

UCB will consider Donation, Grant or Sponsorship requests relevant to several key areas of interest in Immunology and Neurology such as the following (alphabetically listed):

Axial Spondyloarthritis / Ankylosing Spondylitis
Parkinson's Disease
Bone (Low Bone Mass Disorder)Psoriatic Arthritis
Crohn's DiseaseRestless Legs Syndrome
EpilepsyRheumatoid Arthritis
Family Planning and PregnancySystemic Lupus Erythematosus

How to Apply

Requests must be received at least 60 days prior to the date of the programme or event in order to be considered for funding.

All requests are reviewed on the basis of merit, unmet needs, company areas of interest, compliance with legal, ethical and professional obligations and fiscal responsibility.

Discretionary funding decisions are made by UCB and communicated to the party submitting the request.

If your request is directed to UCB Corporate Headquarters, or a UCB affiliate for one of the following countries, follow this link to submit a Sponsorship request: https://erequest.ucb.com/

  • Africa and Middle-East: all countries;
  • Europe and EFPIA* representation: all countries;
  • Asia: all countries except China;
  • Americas: all countries (for the USA, please consult the dedicated US page).

For Australia & China, or for further guidance, kindly contact the UCB Medical Affairs department in your country for assistance.

* The EFPIA (European Federation of Pharmaceutical Industries and Associations) includes 33 national associations: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic (the), Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Netherlands (the), Norway, Poland, Portugal, Romania, Russian Federation (the), Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom (the).